Oryzon Genomics S.A. (ORY.MC)

EUR 2.8

(1.63%)

Inventory Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual inventory in 2023 was 6029.00 EUR , down -38.47% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly inventory in 2024 Q3 was - EUR , down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported annual inventory of 9798.00 EUR in 2022, down -90.56% from previous year.
  • Oryzon Genomics S.A. reported annual inventory of 103.79 Thousand EUR in 2021, down -67.24% from previous year.
  • Oryzon Genomics S.A. reported quarterly inventory of - EUR for 2024 Q3, down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported quarterly inventory of 7125.00 EUR for 2024 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Oryzon Genomics S.A. (2023 - 2019)

Historical Annual Inventory of Oryzon Genomics S.A. (2023 - 2019)

Year Inventory Inventory Growth
2023 6029.00 EUR -38.47%
2022 9798.00 EUR -90.56%
2021 103.79 Thousand EUR -67.24%
2020 316.83 Thousand EUR 0.0%
2019 - EUR 0.0%

Peer Inventory Comparison of Oryzon Genomics S.A.

Name Inventory Inventory Difference
Atrys Health, S.A. 1.67 Million EUR 99.64%
Biotechnologies Assets SA -3.15 Million EUR 100.191%
Pharma Mar, S.A. 39.28 Million EUR 99.985%
Laboratorios Farmaceuticos Rovi, S.A. 337.96 Million EUR 99.998%